Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Zuzana Walker, Federica Gandolfo, Stefania Orini, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2018) Vol. 45, Iss. 9, pp. 1534-1545
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Gaël Chételat, Javier Arbizu, Henryk Barthel, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 11, pp. 951-962
Open Access | Times Cited: 390
Distribution patterns of tau pathology in progressive supranuclear palsy
Gábor G. Kovács, Milica Ječmenica‐Lukić, David J. Irwin, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 2, pp. 99-119
Open Access | Times Cited: 314
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Silvia Morbelli, Giuseppe Esposito, Javier Arbizu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2020) Vol. 47, Iss. 8, pp. 1885-1912
Open Access | Times Cited: 185
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Éric Guedj, Andrea Varrone, Ronald Boellaard, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 2, pp. 632-651
Open Access | Times Cited: 176
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
Flavio Nobili, Javier Arbizu, Femke H. Bouwman, et al.
European Journal of Neurology (2018) Vol. 25, Iss. 10, pp. 1201-1217
Open Access | Times Cited: 174
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 47
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 6
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
Dimitrios Saredakis, Lyndsey E. Collins‐Praino, Daria S. Gutteridge, et al.
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 20-31
Closed Access | Times Cited: 108
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
Peter J. Nestor, Daniele Altomare, Cristina Festari, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2018) Vol. 45, Iss. 9, pp. 1509-1525
Open Access | Times Cited: 101
The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 87
Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases
Vaibhav Sharma, Fredrik Nikolajeff, Saroj Kumar
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Selected Biomarkers of Oxidative Stress and Energy Metabolism Disorders in Neurological Diseases
Izabela Korczowska‐Łącka, Mikołaj Hurła, Natalia Banaszek, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 4132-4149
Open Access | Times Cited: 22
Metabolic patterns across core features in dementia with lewy bodies
Silvia Morbelli, A. Chincarini, Matthias Brendel, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 715-725
Closed Access | Times Cited: 53
Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?
R Ferrando, Andrés Damián
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 39
Biomarker‐Based Approach to α‐Synucleinopathies: Lessons from Neuropathology
Gábor G. Kovács, Lea T. Grinberg, Glenda M. Halliday, et al.
Movement Disorders (2024)
Open Access | Times Cited: 4
IRMA: Machine learning-based harmonization of $$^{18}$$F-FDG PET brain scans in multi-center studies
Sofie Lövdal, Rick van Veen, Giulia Carli, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes
Ralph Buchert, Carsten Buhmann, Ivayla Apostolova, et al.
Deutsches Ärzteblatt international (2019)
Open Access | Times Cited: 36
Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
Gilles N. Stormezand, Lumi T. Chaves, David Vállez García, et al.
NeuroImage Clinical (2020) Vol. 25, pp. 102161-102161
Open Access | Times Cited: 34
FDG‐PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome
Jacy Bezerra Parmera, Artur Martins Coutinho, Mateus Rozalem Aranha, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 651-661
Closed Access | Times Cited: 34
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing Field
Antoine Verger, Stéphan Grimaldi, Maria-João Ribeiro, et al.
Annals of Neurology (2021) Vol. 90, Iss. 5, pp. 711-719
Open Access | Times Cited: 31
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
Ruiqing Ni, Roger M. Nitsch
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 21
FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder
Rick van Veen, Sanne K. Meles, Remco J. Renken, et al.
Computer Methods and Programs in Biomedicine (2022) Vol. 225, pp. 107042-107042
Open Access | Times Cited: 21
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
Sabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 423-434
Open Access | Times Cited: 21
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective
Stéphane Thobois, Stéphane Prange, Christian Scheiber, et al.
Parkinsonism & Related Disorders (2018) Vol. 59, pp. 93-100
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top